High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis–Infected Macrophages to CD8 T Cells

Author:

Mott Daniel12ORCID,Yang Jason12ORCID,Baer Christina2ORCID,Papavinasasundaram Kadamba2ORCID,Sassetti Christopher M.12,Behar Samuel M.12ORCID

Affiliation:

1. *Immunology and Microbiology Program, Graduate School of Biomedical Science, Worcester, MA

2. †Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA

Abstract

Abstract We used a mouse model to study how Mycobacterium tuberculosis subverts host defenses to persist in macrophages despite immune pressure. CD4 T cells can recognize macrophages infected with a single bacillus in vitro. Under identical conditions, CD8 T cells inefficiently recognize infected macrophages and fail to restrict M. tuberculosis growth, although they can inhibit M. tuberculosis growth during high-burden intracellular infection. We show that high intracellular M. tuberculosis numbers cause macrophage death, leading other macrophages to scavenge cellular debris and cross-present the TB10.4 Ag to CD8 T cells. Presentation by infected macrophages requires M. tuberculosis to have a functional ESX-1 type VII secretion system. These data indicate that phagosomal membrane damage and cell death promote MHC class I presentation of the immunodominant Ag TB10.4 by macrophages. Although this mode of Ag presentation stimulates cytokine production that we presume would be host beneficial, killing of uninfected cells could worsen immunopathology. We suggest that shifting the focus of CD8 T cell recognition to uninfected macrophages would limit the interaction of CD8 T cells with infected macrophages and impair CD8 T cell–mediated resolution of tuberculosis.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference79 articles.

1. World Health Organization . 2021. Global Tuberculosis Report 2021.World Health Organization, Geneva, Switzerland. Available at: https://www.who.int/publications/i/item/9789240037021.

2. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials;Mangtani;Clin. Infect. Dis.,2014

3. History of BCG vaccine;Luca;Maedica (Bucur),2013

4. Immunity to tuberculosis;North;Annu. Rev. Immunol.,2004

5. Tuberculosis;Furin;Lancet,2019

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3